Amphenol (APH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Central Puerto (CEPU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Palantir raises its 2026 revenue outlook as Q3 sales surge 96% on AI demand, fueled by U.S. commercial growth, stronger margins and expanding customer spending.
Palantir's 96% revenue growth, rising earnings estimates and strong cash flow support its AI expansion, but a steep valuation raises questions about holding the stock.
TSM's $2 billion deal with GlobalFoundries could ease AI packaging bottlenecks and expand CoWoS capacity, but benefits hinge on a successful 2028 ramp.
Japan's unexpected Q3 GDP contraction raises questions for ETF investors, but resilient corporate investment growth offers reasons to watch the market.
Investors seeking nuclear energy growth opportunities may consider NXE, CW and CEG, given their expertise in uranium, nuclear technology and power generation.
Cadiz (CDZI) delivered earnings and revenue surprises of -14.29% and -52.65%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -10.00% and +0.30%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?